Who
Oxford Science Enterprises plc
Other role
Company insider
Files Form 4 as: 10% owner and Other, Barinthus Biotherapeutics; 10% owner and Other, PepGen.
In numbers
- Trades disclosed
- 17
- Buys
- 3
- Sells
- 0
- Bought
- $21.4M
- Sold
- $0
- Companies
- 2
- Companies where not an officer
- 2
- First trade
- 4 May 2021
- Last trade
- 9 Sep 2026
- Last filed
- 11 Sep 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 9 Sep 2026filed 11 Sep 2026 | Barinthus BiotherapeuticsBiotechnology | SEC FORM 4 Code U | $977K8,797,770 at $0.111 | filing |
| 9 Sep 2026filed 11 Sep 2026 | Barinthus BiotherapeuticsBiotechnology | SEC FORM 4 Code U | $968K8,797,770 at $0.11 | filing |
| 30 Sep 2025filed 1 Oct 2025 | PEPG PepGenBiotechnology | SEC FORM 4 Bought | $640K200,000 at $3.20 | filing |
| 10 May 2022filed 9 Apr 2024 | PEPG PepGenBiotechnology | SEC FORM 4 Bought | $10.6M879,970 at $12.00 | filing |
| 10 May 2022filed 10 May 2022 | PEPG PepGenoption or derivative · Biotechnology | SEC FORM 4 Code C | —1,285,720 at $0.00 | filing |
| 10 May 2022filed 10 May 2022 | PEPG PepGenoption or derivative · Biotechnology | SEC FORM 4 Code C | —962,884 at $0.00 | filing |
| 10 May 2022filed 10 May 2022 | PEPG PepGenoption or derivative · Biotechnology | SEC FORM 4 Code C | —1,575,572 at $0.00 | filing |
| 10 May 2022filed 10 May 2022 | PEPG PepGenBiotechnology | SEC FORM 4 Code C | —1,262,986 at $0.00 | filing |
| 10 May 2022filed 10 May 2022 | PEPG PepGenBiotechnology | SEC FORM 4 Code C | —945,859 at $0.00 | filing |
| 10 May 2022filed 10 May 2022 | PEPG PepGenBiotechnology | SEC FORM 4 Code C | —1,547,713 at $0.00 | filing |
| 4 May 2021filed 6 May 2021 | Barinthus Biotherapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code C | —4,832,142 | filing |
| 4 May 2021filed 6 May 2021 | Barinthus Biotherapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code C | —1,704,444 | filing |
| 4 May 2021filed 6 May 2021 | Barinthus Biotherapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code C | —1,661,184 | filing |
| 4 May 2021filed 6 May 2021 | Barinthus BiotherapeuticsBiotechnology | SEC FORM 4 Code C | —4,832,142 | filing |
| 4 May 2021filed 6 May 2021 | Barinthus BiotherapeuticsBiotechnology | SEC FORM 4 Code C | —1,704,444 | filing |
| 4 May 2021filed 6 May 2021 | Barinthus BiotherapeuticsBiotechnology | SEC FORM 4 Code C | —1,661,184 | filing |
| 4 May 2021filed 6 May 2021 | Barinthus BiotherapeuticsBiotechnology | SEC FORM 4 Bought | $10.2M600,000 at $17.00 | filing |
News
No headline names them, or the companies they trade most, lately.